Ticlopidine in the secondary prevention of early diabetes-related microangiopathy: protocol of a multicenter therapeutic study (TIMAD study).
D000244:Adenosine Diphosphate / Q000494:pharmacology; D000293:Adolescent; D000328:Adult; D000368:Aged; D000925:Anticoagulants / Q000627:therapeutic use*; D002545:Brain Ischemia / Q000517:prevention & control; D002986:Clinical Trials as Topic; D003925:Diabetic Angiopathies / Q000503:physiopathology / Q000517:prevention & control*; D003929:Diabetic Neuropathies / Q000503:physiopathology; D003930:Diabetic Retinopathy / Q000517:prevention & control; D004562:Electrocardiography; D005451:Fluorescein Angiography; D005500:Follow-Up Studies; D006801:Humans; D008875:Middle Aged; D010349:Patient Compliance; D010974:Platelet Aggregation / Q000187:drug effects; D013876:Thiophenes / Q000627:therapeutic use*; D013988:Ticlopidine
D000925:Anticoagulants; D013876:Thiophenes; D000244:Adenosine Diphosphate; D013988:Ticlopidine